Related Experiment Videos
Laser palliation for colorectal carcinoma
N Mandava1, N Petrelli, L Herrera
1Department of Surgical Oncology and Endoscopy, Roswell Park Cancer Institute, Buffalo, New York 14263.
American Journal of Surgery
|September 1, 1991
Summary
Endoscopic neodymium:yttrium-aluminium-garnet (Nd:YAG) laser therapy effectively palliated colorectal carcinoma symptoms in 23 of 27 patients. This palliative treatment showed a high success rate for symptom relief with minimal complications.
Area of Science:
- Gastroenterology
- Oncology
- Medical Technology
Background:
- Colorectal carcinoma presents a significant palliative care challenge.
- Endoscopic therapies offer minimally invasive options for symptom management.
Purpose of the Study:
- To evaluate the efficacy and safety of palliative endoscopic neodymium:yttrium-aluminium-garnet (Nd:YAG) laser treatment for colorectal carcinoma.
- To assess symptom relief and complication rates in patients undergoing Nd:YAG laser therapy.
Main Methods:
- A review of 27 patients with colorectal carcinoma treated with palliative endoscopic Nd:YAG laser therapy.
- Data collected on lesion characteristics, treatment details, complications, and symptom relief.
Main Results:
- The study included 25 rectal and 2 sigmoid colon carcinomas.
- A mean of three Nd:YAG laser treatments were administered, with a mean duration of 40 minutes.
- Symptom relief was achieved in 23 of 27 patients (85%), with 15% experiencing complications.
Conclusions:
- Endoscopic Nd:YAG laser therapy is an effective palliative treatment for colorectal carcinoma.
- The procedure demonstrates a high success rate for symptom palliation with an acceptable safety profile.